American Society of Clinical Oncology (ASCO)

JCO Precision Oncology Conversations

Ascolta mensilmente mentre esperti discutono articoli chiave da JCO Precision Oncology, ospitato dal Dr. Abdul Rafeh Naqash. Rimani informato sulle ultime novità nella cura del cancro di precisione.

Listen on Apple Podcasts

Proteomics Predictor for Immunotherapy Benefit

21 mins • Jan 15, 2025

Episodi recenti

Jan 15, 2025

Proteomics Predictor for Immunotherapy Benefit

21 mins

Dec 18, 2024

Transcriptome and ctDNA Associates with Pembrolizumab Benefit

23 mins

Nov 27, 2024

JCO Precision Oncology Article Insights: Germline Pathogenic Variants in Renal Cell Carcinoma

10 mins

Nov 15, 2024

Uptake of Aspirin Chemoprevention in Lynch Syndrome

31 mins

Oct 30, 2024

JCO PO Article Insights: Talazoparib in Solid Tumors with BRCA1/2 Mutation

7 mins

Lingua
Inglese
Paese
Colombia
Feed Host
Sito web
Request an Update
Updates may take a few minutes.